Benefit and risk in the beta-lactam antibiotic-resistance strategies of Streptococcus pneumoniae and Staphylococcus aureus.
Tomasz
A
A
Laboratory of Microbiology, Rockefeller University, New York, NY 10021.
D000222:Adaptation, Physiological; D001426:Bacterial Proteins; D002352:Carrier Proteins / Q000096:biosynthesis; D002473:Cell Wall / Q000737:chemistry; D006602:Hexosyltransferases; D016106:Methicillin Resistance / Q000235:genetics; D002267:Muramoylpentapeptide Carboxypeptidase / Q000096:biosynthesis; D010403:Penicillin Resistance / Q000235:genetics / Q000502:physiology*; D046915:Penicillin-Binding Proteins; D010457:Peptidoglycan / Q000737:chemistry; D010458:Peptidyl Transferases; D013211:Staphylococcus aureus / Q000235:genetics* / Q000472:pathogenicity; D013296:Streptococcus pneumoniae / Q000472:pathogenicity / Q000502:physiology*; D014774:Virulence
D001426:Bacterial Proteins; D002352:Carrier Proteins; D046915:Penicillin-Binding Proteins; D010457:Peptidoglycan; D010458:Peptidyl Transferases; D006602:Hexosyltransferases; D002267:Muramoylpentapeptide Carboxypeptidase